‌

US Patent 8586714 Dual variable domain immunoglobulins and uses thereof

Patent 8586714 was granted and assigned to AbbVie Inc. on November, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

AbbVie Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8586714

Date of Patent

November 19, 2013

Patent Application Number

12873926

Date Filed

September 1, 2010

Patent Citations Received

‌

US Patent 12115191 Methods of treating age-related and inflammatory diseases

‌

US Patent 12018071 Single-chain chimeric polypeptides and uses thereof

‌

US Patent 12024545 Methods of treating aging-related disorders

‌

US Patent 12077783 AAV-mediated delivery of antibodies to the inner ear

‌

US Patent 11672826 Methods of treating aging-related disorders

‌

US Patent 11697801 AAV-mediated delivery of therapeutic antibodies to the inner ear

‌

US Patent 11884712 Multi-chain chimeric polypeptides and uses thereof

‌

US Patent 11987619 Single-chain chimeric polypeptides and uses thereof

...

Patent Primary Examiner

‌

Phuong Huynh

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8586714 Dual variable domain immunoglobulins and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API